WASHINGTON DC (March 8, 2019) —

Patient Affairs Staff (PAS)

Food and Drug Administration

US Department of Health and Human Services

 

The FDA Patient Affairs Staff would like to share an exciting announcement — the FDA “Request to Connect” portal is now live: www.fda.gov/RequestToConnect.

This new patient portal gives patients and caregivers a single-entry point to the Agency for questions and meeting requests. Co-developed by the Patient Affairs Staff and the medical product centers, the portal will route inquiries to the appropriate medical-product center or office to ensure that they are received and responded to in an effective and efficient manner. As patient populations and their needs evolve and become increasingly complex, Patient Affairs want patients and those who advocate on their behalf to know that our door is open. As a science-based agency, we continue to develop and engage programs that help FDA understand the patient perspective and advance the science of patient input.

To learn more about ways that patients and caregivers can get involved at FDA, contact the Patient Affairs Staff (PAS), or check out our latest video — Patients Matter: Giving Patients A Seat at the Table. We’re also on Twitter: @FDAPatientInfo.

Support the River Cities' Reader

Get 12 Reader issues mailed monthly for $48/year.

Old School Subscription for Your Support

Get the printed Reader edition mailed to you (or anyone you want) first-class for 12 months for $48.
$24 goes to postage and handling, $24 goes to keeping the doors open!

Click this link to Old School Subscribe now.



Help Keep the Reader Alive and Free Since '93!

 

"We're the River Cities' Reader, and we've kept the Quad Cities' only independently owned newspaper alive and free since 1993.

So please help the Reader keep going with your one-time, monthly, or annual support. With your financial support the Reader can continue providing uncensored, non-scripted, and independent journalism alongside the Quad Cities' area's most comprehensive cultural coverage." - Todd McGreevy, Publisher